Lung cancer treatment (Multidisciplinary treatment of lung cancer)

What is lung cancer treatment?

Lung cancer treatment is the overall plan to remove or control the cancer and ease symptoms. It is not a single operation or drug. Depending on the type and stage, it may combine surgery, radiotherapy, chemotherapy, immunotherapy and targeted drugs, given in an order chosen for you.

The two main groups are non-small cell lung cancer (the most common) and small cell lung cancer, which behave differently and are treated differently. Decisions are made by a multidisciplinary team (MDT) and depend on the type, the stage (how far the cancer has spread), your lung function and general health, and molecular tests on the cancer. Those molecular tests — looking for changes such as EGFR or ALK, and for the PD-L1 marker — strongly affect whether targeted drugs or immunotherapy are likely to help.

For some people with early lung cancer the aim is to cure or to lower the chance of the cancer returning. For lung cancer that has spread, the usual aim is to control it for as long as possible and keep you well, rather than to cure it. Your team should tell you honestly which applies to you and what a good result would look like.

This guide gives an overview of the whole pathway. The detail of your own plan will come from your lung specialist, oncologist and specialist nurse.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

Surgery compared with radiotherapy for early lung cancer

For some early lung cancers both can be options. The right choice depends on the cancer, your lung function and fitness, and your preferences. Your MDT will advise.

Preparing for your treatment

• Ask your team to explain the type and stage of your cancer and the aim of treatment.
• Make sure molecular tests on the cancer (such as EGFR, ALK and PD-L1) are complete, as these guide treatment.
• Expect tests of your lung function and general fitness, especially if surgery is considered.
• Bring a list of your medicines, supplements and allergies.
• Stop smoking if you can — support is available, and it can help treatment and recovery.
• Take someone to appointments and write down your questions.
• If having surgery, follow the specific preparation advice for your operation.

What happens

After diagnosis and staging, your case is discussed by an MDT that includes lung specialists, surgeons, oncologists, radiologists, pathologists and specialist nurses. They use your scans, biopsy results, molecular tests and lung function to recommend a plan, which they discuss with you.

The order and mix of treatment depend on the type and stage. Earlier non-small cell lung cancer may be treated with surgery or precise radiotherapy, sometimes with chemotherapy or immunotherapy before or after. More advanced disease is often treated with drug treatment — chemotherapy, immunotherapy, targeted drugs or combinations — guided by molecular results. Small cell lung cancer is usually treated mainly with chemotherapy, often with radiotherapy or immunotherapy.

Each part of the pathway has its own process and timeline. Surgery is a hospital procedure with a recovery period; radiotherapy is usually a series of sessions; drug treatments are given in cycles over weeks or months. Throughout, you have regular reviews with scans to check how treatment is working and to manage side effects and symptoms.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

Comfort, sedation or contrast choices

If local anaesthetic, sedation, contrast or pain relief is used, ask what is planned, why, and what it means afterwards.

Risks depend on which treatments you have and on your lung function, so use this overview alongside the detailed information for each part of your plan. Important things to discuss are the effect on your breathing, the specific side effects of your drugs, and the immune-related side effects of immunotherapy, which can affect many parts of the body and need prompt attention. If you have chemotherapy, understand the warning signs of infection, as a fever can become an emergency quickly.

Published figures to discuss

Outcomes and side-effect rates vary widely depending on the type (non-small cell or small cell), the stage, the molecular features, the treatments used and the person's lung function and health, so single percentages can mislead. Survival depends heavily on stage at diagnosis. Reliable general statistics are published by Cancer Research UK and broken down by stage; your own outlook should be discussed with your oncologist. We have not quoted survival or response percentages here because they depend so strongly on individual circumstances.

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

Recovery depends on which treatments you have and in what order. Lung surgery has a physical recovery and may affect your breathing; drug treatments and radiotherapy have their own patterns. Your team will set out what to expect for your plan.

• Tiredness during and after treatment
• Breathlessness on exertion, especially after lung surgery, often improving with time and rehabilitation
• A cough or chest discomfort that settles
• Emotional ups and downs, which are common and understandable
• Gradual return of energy over weeks to months after active treatment

Aftercare

• Take all treatments as prescribed and tell your team about side effects rather than stopping on your own.
• Do breathing exercises and stay as active as advised, especially after surgery.
• Attend all follow-up appointments and scans.
• Stop smoking if you can — it helps recovery and ongoing treatment; ask for support.
• Report new or worsening breathlessness, chest pain or other symptoms promptly.
• If on chemotherapy, keep the 24-hour helpline number and check your temperature if unwell.
• For immunotherapy, report new diarrhoea, breathlessness, severe tiredness or yellow skin urgently.

• A written summary of your treatment plan and its aim
• Contact details for your lung cancer nurse and the 24-hour helpline
• A schedule of follow-up appointments and scans
• A thermometer at home if you are having chemotherapy
• A list of your current medicines
• Stop-smoking support arranged if relevant
• Your GP informed and included in your care

Scars and how they heal

Lung surgery leaves scars whose size depends on the approach — small scars with keyhole (VATS) surgery, or a larger scar with open surgery. Scars are firm and pink at first and fade over months. Your surgeon will explain what to expect and how to care for the wound. Drug treatment and radiotherapy do not leave surgical scars, though a line or port for infusions leaves a small mark.

⚠ Get urgent help if…

• If on chemotherapy: a temperature, shivering or feeling very unwell — contact the helpline immediately, this can be a serious infection
• Sudden or worsening breathlessness, or coughing up blood — seek urgent help
• Chest pain, or a hot, swollen, painful leg (possible clot)
• For immunotherapy: new severe diarrhoea, breathlessness, severe tiredness or yellow skin — these can be serious and need urgent review
• A wound that becomes red, hot, swollen or leaks fluid after surgery
• A severe allergic reaction during drug treatment (rash, breathlessness, swelling)
• High fever, productive cough or feeling very unwell (possible chest infection)

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A good result depends on the aim of treatment. For early lung cancer, success means the cancer is removed or controlled and the chance of it returning is reduced. For advanced lung cancer, success means controlling the cancer and symptoms and keeping you well, sometimes for a long time, especially when targeted drugs or immunotherapy suit the cancer.

No treatment can guarantee a cure or that the cancer will not return, and honest teams will not promise this. Outcomes depend heavily on the type, stage and molecular features of the cancer and on how it responds. Cancer Research UK publishes general survival statistics by stage; your own outlook should be discussed with your oncologist. For published statistics, see Cancer Research UK rather than any single clinic's figures.

How long the benefit of treatment lasts depends on the type, stage and how the cancer responds. Some targeted drugs and immunotherapy can control advanced lung cancer for a long time, but benefit can wear off if the cancer becomes resistant, and treatment may be changed. After treatment with curative intent, follow-up continues for years because lung cancer can come back.

Related tests, treatments or support

Lung cancer treatment often combines approaches — for example surgery with chemotherapy or immunotherapy before or after, or chemotherapy combined with radiotherapy (chemoradiation) or immunotherapy. Molecular tests guide which drugs are added. Supportive care helps with symptoms such as breathlessness and pain. Your MDT decides the combination and sequence for your cancer.

Follow-up & long-term care

After active treatment you have regular follow-up with scans to check for any sign of the cancer returning and to manage symptoms. Immunotherapy and targeted drugs continue under review when used. Care is often shared between hospital teams and your GP. Report new or worsening symptoms, especially breathlessness, promptly between appointments.

• Ongoing immunotherapy or targeted drugs with regular review when used
• Regular follow-up appointments and scans
• Pulmonary rehabilitation or breathing support where helpful
• Stopping smoking and general health measures
• Prompt reporting of new symptoms and clear shared records across all teams

Repeat, follow-on and what comes next

• Drug treatment may be changed, reduced or stopped depending on side effects and response.
• If a targeted drug or immunotherapy stops working, the team may switch to a different treatment.
• Further treatment may be needed if the cancer returns or progresses.
• For advanced lung cancer, the plan is reviewed regularly and the aim of treatment can change over time.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

• A named lung cancer nurse and a 24-hour helpline for problems during treatment.
• A written treatment summary and a clear follow-up plan including scans.
• Prompt recognition and management of side effects, including immune-related effects.
• Breathing support or pulmonary rehabilitation where helpful, and stop-smoking support.
• Records shared so your GP and any NHS and private teams work from one plan.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

• Which treatments are needed — surgery, radiotherapy, chemotherapy, immunotherapy or targeted drugs
• Surgeon, oncologist and facility fees for each part of the plan
• Specific drugs used and the number of cycles
• Scans, biopsies, lung function tests and molecular tests needed to plan and monitor treatment
• Length of stay if surgery is needed
• Ongoing immunotherapy or targeted drugs and the reviews that go with them
• Management of side effects, including any unplanned admissions

• Which treatments are included in the plan and their separate fees
• Surgeon, oncologist and facility costs
• Drugs, number of cycles and how they are charged
• Scans, biopsies, lung function and molecular tests, and who reports them
• Follow-up appointments and imaging
• What happens, and who pays, if you need treatment for a complication
• How care is shared with the NHS and what the NHS continues to provide

On the NHS? Lung cancer treatment is widely available on the NHS when clinically indicated; paying privately does not change the standard treatment or buy a better outcome, but may be used for speed, choice of setting, and should be coordinated with your NHS team.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Consent traps and marketing red flags

These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.

Choosing a specialist safely

• Check the specialist is on the GMC Specialist Register for this area.
• Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
• You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
• Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
• You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Take this to your consultation. A good specialist will welcome every one of these.

• What type and stage is my lung cancer, and what is the aim of treatment for me?
• Which treatments do you recommend, in what order, and why?
• What do the molecular tests on my cancer mean for targeted treatment or immunotherapy?
• How will treatment affect my breathing, and what are the main side effects?
• Which side effects are emergencies, and who do I call?
• How will my care be coordinated between any private treatment and the NHS?
• Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
• Will you be the specialist who carries out my treatment, and who looks after me afterwards?
• What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
• What does a realistic result look like — and what can this treatment not achieve?
• What are my options, including waiting, doing nothing for now, or choosing a different approach?
• Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
• What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Find a verified specialist for lung cancer treatment

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: NHS — Lung cancer: treatment Cancer Research UK — Treatment options for non-small cell lung cancer Cancer Research UK — Targeted and immunotherapy treatment for lung cancer Cancer Research UK — Chemotherapy for lung cancer Macmillan — Lung cancer treatment Macmillan — Chemotherapy for lung cancer

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.